Literature DB >> 18812577

Influence of Helicobacter hepaticus infection on the chronic toxicity and carcinogenicity of triethanolamine in B6C3F1 mice.

Matthew D Stout1, Grace E Kissling, Fernando A Suárez, David E Malarkey, Ronald A Herbert, John R Bucher.   

Abstract

Helicobacter hepaticus (H. hepaticus) infection causes hepatitis and increased hepatocellular neoplasms in male mice; although females are also infected, liver lesions are not typically expressed. In the 1990s, B6C3F1 mice from some chronic National Toxicology Program (NTP) studies were found to be infected with H. hepaticus. In these studies, there was hepatitis in many of the males, and there were more hepatocellular neoplasms in control males compared to studies with uninfected mice. In one of these studies, increased hepatocellular neoplasms at the high doses in male and female mice exposed topically to triethanolamine (TEA) provided the only evidence of carcinogenic activity. This study was repeated in mice free of H. hepaticus.However, the NTP mouse production colony and the diet differed between studies; these differences were the result of NTP programmatic decisions. In repeat study males, although control incidences were similar between studies, exposure did not result in increased hepatocellular neoplasms. In repeat study females, the control incidence of hepatocellular neoplasms was half that observed in the initial study, and these neoplasms were increased over controls at all doses. These data suggest that in the initial study, H. hepaticusinfluenced the induction of hepatocellular neoplasms in males, but not in females.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812577      PMCID: PMC2719836          DOI: 10.1177/0192623308322312

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  22 in total

1.  Effect of diet and housing on growth, body weight, survival and tumor incidences of B6C3F1 mice in chronic studies.

Authors:  Ghanta N Rao; Patrick W Crockett
Journal:  Toxicol Pathol       Date:  2003 Mar-Apr       Impact factor: 1.902

2.  Testing for increased carcinogenicity using a survival-adjusted quantal response test.

Authors:  C J Portier; A J Bailer
Journal:  Fundam Appl Toxicol       Date:  1989-05

3.  The comparison of several dose levels with a zero dose control.

Authors:  D A Williams
Journal:  Biometrics       Date:  1972-06       Impact factor: 2.571

4.  A test for differences between treatment means when several dose levels are compared with a zero dose control.

Authors:  D A Williams
Journal:  Biometrics       Date:  1971-03       Impact factor: 2.571

5.  Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice.

Authors:  Arlin B Rogers; Samuel R Boutin; Mark T Whary; Nataliya Sundina; Zhongming Ge; Kathleen Cormier; James G Fox
Journal:  Toxicol Pathol       Date:  2004 Nov-Dec       Impact factor: 1.902

6.  Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice.

Authors:  Claude M Nagamine; Arlin B Rogers; James G Fox; David B Schauer
Journal:  Int J Cancer       Date:  2008-02-15       Impact factor: 7.396

7.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

9.  Chronic active hepatitis in mice caused by Helicobacter hepaticus.

Authors:  J M Ward; M R Anver; D C Haines; R E Benveniste
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

10.  Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples.

Authors:  A J Bailer; C J Portier
Journal:  Biometrics       Date:  1988-06       Impact factor: 2.571

View more
  1 in total

1.  Distance burning: how gut microbes promote extraintestinal cancers.

Authors:  Arlin B Rogers
Journal:  Gut Microbes       Date:  2011 Jan-Feb
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.